Home » Topics » Science » New compound

New compound
RSS

Thrombin inhibitors submitted to SAR studies at DuPont Merck

Jan. 24, 1997

Glaxo Wellcome selects anticonvulsant compound for further study

Jan. 24, 1997

New tool for studying phosphodiesterase receptors

Jan. 23, 1997

New AMPA receptor modulator described by Servier

Jan. 23, 1997

Neuroprotective agent described by Taisho

Jan. 16, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New analgesic agent described by Japanese academics

Jan. 10, 1997

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Jan. 10, 1997

Korean researchers report new immunosuppressant from natural source

Jan. 10, 1997

Antileukemic bisabolane sesquiterpene isolated from natural sources

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...